• Scott
• ,  Contributor
• 24 September 2018, 11:09 am

This ought to be a pretty good short squeeze, short interest was at nearly 16% of float before the announcement - that was 9 days to cover according to the NASDAQ short interest site

   0   Reply (0)   Edit    Delete

• Jesse
• ,  Contributor
• 24 September 2018, 11:09 am

From Merrill Lynch and Research Analyst Tazeen Ahmad: Nuplazid monthly scripts data show improvement in LTC channel LTC prescription data support positive outlook VIA IMS and Symphony Health Solutions (SHS) monthly scripts data of Nuplazid suggest improv

   0   Reply (0)   Edit    Delete

• John R
• ,  Contributor
• 24 September 2018, 11:09 am

FDA released statement - no new safety risks.\n

   0   Reply (0)   Edit    Delete

• Harry Rush
• ,  Contributor
• 24 September 2018, 11:09 am

BAKER BROS, we are going $22 today\n

   0   Reply (0)   Edit    Delete